Beckley Psytech This story is available exclusively to Insider subscribers. Become an Insider and start reading now.
UK-based psychedelics company Beckley Psytech just closed an $18.6 million funding round, backed by investment firms Noetic Psychedelic Fund and Bail Capital.
Beckley Psytech s upcoming clinical trials will be focused on researching the synthetic compound 5-MeO-DMT, a psychedelic agent found naturally in the Sonoran Desert toad.
The company says it s preparing to test other compounds as well.
Cosmo Feilding Mellen was involved in the world of psychedelics long before the compounds started to become mainstream.
Feilding Mellen is the cofounder and CEO of UK-based psychedelics company Beckley Psytech, but his family and his mother Amanda Feilding, in particular has been involved in the scientific studies around psychedelics since 1998. That s the year Feilding started the Beckley Foundation, a n
Deals of the Week, December 11 to 18 – Growth Business roundup 18 Dec 2020
Growth Business roundup of Deals of the Week December 11 to 18, listing seed funding, venture capital and crowdfunding deals of note
Triple support for eXate with three investors raising £2.3m in seed round
eXate, a London-based data software firm, has announced a £2.3m seed round led by Outward VC, with additional backing from ING Ventures and Triple Point Ventures.
The funding will enable eXate to grow its team, accelerating platform development and expanding into new geographies and verticals.
Triple Point invests in various areas with societal significance including energy efficiency and social housing. It currently manages over £1.8bn of private, institutional and public capital.
Healthy Smoothies Industry | Competitive Dynamics and Market Trend by 2023 comunicati.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from comunicati.net Daily Mail and Mail on Sunday newspapers.